High Affinity Rheumatoid Factor Transgenic B Cells Are Eliminated in Normal Mice

Journal of Immunology

Volumn 159, Issue 3, 1997, Pages 1125-1134

  Wang, Haowei ^a   Shlomchik, Mark J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR; RHEUMATOID FACTOR;

ANIMAL; ANTIBODY AFFINITY; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; BLOOD; BONE MARROW; BREEDING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HYBRIDOMA; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MOUSE; SPLEEN; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODY AFFINITY; B-LYMPHOCYTES; BONE MARROW; BREEDING; CLONAL DELETION; HYBRIDOMAS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, B-CELL; RHEUMATOID FACTOR; SPLEEN; TRANSGENES;

EID: 0031205293     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Tan, E. M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44:93.
2. Notman, D. D., N. Kurata, and E. M. Tan. 1974. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann. Intern. Med. 83:464.
3. Rose, H., C. Ragan, E. Pearie, and M. Lipman. 1948. Differential agglutination of normal sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc. Soc. Exp. Biol. Med. 68:1.
4. Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177:999.
5. Radic, M. Z., J. Erikson, S. Litwin, and M. Weigert. 1993. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177:1165.
6. Chen, C., Z. Nagy, M. Z. Radic, R. R. Hardy, D. Huszar, S. A. Camper, and M. Weigert. 1995. The site and stage of anti-DNA B-cell deletion. Nature 373: 252.
7. Okamoto, M., M. Murakami, A. Shimizu, S. Ozaki, T. Tsubata, S. Kumagi, and T. Honjo. 1992. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 175:71.
8. Shlomchik, M. J., D. Zharhary, S. Camper, T. Saunders, and M. Weigert. 1993. A rheumatoid factor transgenic mouse model of autoantibody regulation. Int. Immunol. 5:1329.
9. Hannum, L. G., D. Ni, A. M. Haherman, M. G. Weigert, and M. J. Shlomchik. 1996. A disease-related RH autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J. Exp. Med. 184:1269.
10. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
11. Coleclough, C., R. P. Perry, K. Karjalainen, and M. Weigert. 1981. Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature 290:372.
12. Marcu, K. B., J. Banerji, N. A. Penncavage, R. Lang, and N. Arnheim. 1980. 5′ flanking region of immunoglobulin heavy chain constant region genes display length heterogeneity in germ lines of inbred mouse strain. Cell 22:187.
13. Erikson, J., M. Z. Radic, S. A. Camper, R. R. Hardy, and M. G. Weigert. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349:331.
14. Schultz, C., J. Petrini, J. Collins, J. L. Claflin, K. A. Denis, P. Gearhart, C. Gritzmacher, T. Manser, M. Shulman, and W. Dunnick. 1990. Patterns and extent of isotype-specificity in the murine H chain switch DNA rearrangement. J. Immunol. 144:363.
15. Wolfowicz, C. B., P. Sakorasas, T. L. Rothstein, and A. Marshak-Rothstein. 1988. Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice. Clin. Immunol. Immunopathol. 46:382.
16. Pulendran, B., K. G. C. Smith, and G. J. V. Nossal. 1995. Soluble antigen can impede affinity maturation and the germinal center reaction but enhance extrafollicular immunoglobulin production. J. Immunol. 155:1141.
17. Oi, V. T., and L. A. Herzenberg. 1979. Localization of murine Ig-1b and Ig-1a (IgG 2a) allotypic determinations detected with monoclonal antibodies. Mol. Immunol. 16:1005.
18. Jacobson, B. A., J. Sharon, H. Shan, M. Shlomchik, M. G. Weigert, and R. A. Marshak. 1994. An isotype switched and somatically mutated rheumatoid factor clone isolated from a MRL-lpr/lpr mouse exhibits limited intraclonal affinity maturation. J. Immunol. 152:4489.
19. Nemazee, D., D. Russell, B. Arnold, G. Haemmerling, J. Allison, J. F. A. P. Miller, G. Morahan, and K. Beurki. 1991. Clonal deletion of autospecific B lymphocytes. Immunol. Rev. 122:117.
20. Nemazee, D. A., and K. Burki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class-I antibody genes. Nature 337:562.
21. Tiegs, S. L., D. M. Russell, and D. Nemazee. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009.
22. Hartley, S. B., J. Crosbie, R. A. Brink, A. B. Kantor, A. Basten, and C. C. Goodnow. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353:765.
23. Hartley, S. B., M. P. Cooke, D. A. Fulcher, A. W. Harris, S. Cory, A. Basten, and C. C. Goodnow. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72:325.
24. Chen, C., M. Z. Radic, J. Erikson, S. A. Camper, S. Litwin, R. R. Hardy, and M. Weigert. 1994. Deletion and editing of B cells that express antibodies to DNA. J. Immunol. 152:1970.
25. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213.
26. Shan, H., M. J. Shlomchik, A. Marshak-Rothstein, D. S. Pisetsky, S. Litwin, and M. G. Weigert. 1994. The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J. Immunol. 153:5104.
27. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, R. J. Trent, and A. Basten. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676.
28. Brombacher, F., G. Kohler, and H. Eibel. 1991. B cell tolerance in mice transgenic for anti-CD8 immunoglobulin mu chain. J. Exp. Med. 174:1335.
29. Phillips, N. E., and D. C. Parker. 1984. Cross-linking of B lymphocyte Fey receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J. Immunol. 132:627.
30. D'Ambrosio, D., K. L. Hippen, S. A. Minskoff, I. Mellman, G. Pani, K. A. Siminovitch, and J. C. Cambier. 1995. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science 268:293.
31. Eisenberg, R. 1976. The specificity and polyvalency of binding of a monoclonal rheumatoid factor. Immunochemistry 13:355.
32. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects of Fas antigen that mediates apoptosis. Nature 356:314.
33. Susa, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
34. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
35. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thomspon, H. Griesser, and T. W. Mak 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270: 985.
36. McCartney-Francis, N. L., D. E. Mizel, R. S. Redman, M. Frazier-Jessen, R. B. Panek, A. B. Kulkarni, J. M. Ward, J. B. McCarthy, and S. M. Wahl. 1996. Autoimmune Sjogren's-like lesions in salivary glands of TGF-β1-deficient mice are inhibited by adhesion-blocking peptides. J. Immunol 157:1306.
37. Rathmell, J. C., and C. C. Goodnow. 1994. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J. Immunol. 153:2831.
38. Rubio, C. F., J. Kench, D. M. Russell, R. Yawger, and D. Nemazee. 1996. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes. J. Immunol. 157:65.
39. Roark, J. H., C. L. Kuntz, K.-A. Nguyen, A. J. Caton, and J. Erikson. 1995. Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med. 181:1157.
40. Roark, J. H., C. L. Kuntz, K. A. Nguyen, L. Mandik, M. Cattermole, and J. Erikson. 1995. B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice. J. Immunol. 154:4444.